Beryl Drugs Q4 Results

  • BSE: 524606
  • NSE: -
  • ISIN: INE415H01017
  • Sector: Biotechnology & Drugs
BSE
33.10.57 (1.75%)
Volume212.00
Updated: Tue 26 Nov, 2024 | 09:07:13
NSE
This stock is not traded on NSE
Today: 33.10
33.10
52-Wk: 20.19
46.00

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Beryl Drugs Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 2.988.15-%6.11-%
    Selling/ General/ Admin Expenses Total 0.490.47-%0.45-%
    Depreciation/ Amortization 0.320.22-%0.15-%
    Other Operating Expenses Total -0.332.86-%2.13-%
    Total Operating Expense 3.507.70-%5.97-%
    Operating Income -0.520.46-%0.14-%
    Net Income Before Taxes -0.420.38-%0.06-%
    Net Income -0.350.14-%0.06-%
    Diluted Normalized EPS -0.680.28-%0.12-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts